A Study of CRN09682 in People With Neuroendocrine Neoplasms (NENs) and Other Solid Tumors

Full Title

A Phase 1/2 Dose Escalation Study of CRN09682 With an Expansion Phase in Participants with Progressive Metastatic Somatostatin Receptor Type 2 (SST2)-Expressing Neuroendocrine Neoplasms (NENs) and Other SST2-Expressing Solid Tumors

Purpose

To learn more about the purpose of this study and to find out who can join, please click here to visit ClinicalTrials.gov for a full clinical trial description.

Contact

For more information or to see if you can join this study, please call Dr. Rohit Thummalapalli’s office at 646-888-4494.

Protocol
26-193
Phase
Phase I/II (phases 1 and 2 combined)
Disease Status
Relapsed or Refractory
Investigator
Rohit Thummalapalli
Co-Investigators
Nitya Raj
Diseases
Solid Tumors
Upper Gastrointestinal › Neuroendocrine
Locations
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Commack Nonna’s Garden Foundation Center
Memorial Sloan Kettering Basking Ridge
Memorial Sloan Kettering Westchester
Memorial Sloan Kettering Monmouth
Memorial Sloan Kettering Bergen
Memorial Sloan Kettering Nassau
ClinicalTrials.gov ID
NCT07129252
ClinicalTrials.gov
Visit ClinicalTrials.gov for full clinical trial description